PUBLICATIONS · 10561265
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1999 Jul
- First author
- Atkins MB
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Atkins MB
- type
- Author
- name
- Lotze MT
- type
- Author
- name
- Dutcher JP
- type
- Author
- name
- Fisher RI
- type
- Author
- name
- Weiss G
- type
- Author
- name
- Margolin K
- type
- Author
- name
- Abrams J
- type
- Author
- name
- Sznol M
- type
- Author
- name
- Parkinson D
- type
- Author
- name
- Hawkins M
- type
- Author
- name
- Paradise C
- type
- Author
- name
- Kunkel L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Atkins MB
- type
- Author
- name
- Lotze MT
- type
- Author
- name
- Dutcher JP
- type
- Author
- name
- Fisher RI
- type
- Author
- name
- Weiss G
- type
- Author
- name
- Margolin K
- type
- Author
- name
- Abrams J
- type
- Author
- name
- Sznol M
- type
- Author
- name
- Parkinson D
- type
- Author
- name
- Hawkins M
- type
- Author
- name
- Paradise C
- type
- Author
- name
- Kunkel L
- type
- Author
- bibliography ids
- nci-bib-bef221a11d87fc35d0a42152
- book metadata
- content sha256
- 8919f850c231d46d4f03c632b0cd07864b0268a4ffae1163742b6432b5293379
- document type
- citation
- dois
- 10.1200/JCO.1999.17.7.2105
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:10561265
- immutable id
- pubmed:10561265@8919f850c231d46d4f03c632b0cd07864b0268a4ffae1163742b6432b5293379
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 7
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2105-16
- volume
- 17
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 10561265
- provenance
- batch id
- 40703d4bdd5a70d2c67a
- provider
- NCBI PubMed ESummary
- record sha256
- f1bf0b9e2eb13cf71a5657d0014ac3290551398b83a42e88adf56351a949e579
- response sha256
- a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
- retrieved at
- 2026-09-09T23:45:35.800055+00:00
- publication date
- display
- 1999 Jul
- precision
- month
- year
- 1999
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- Review
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.
Preserved source evidence · Not medical advice
Triangle